FDA Approves Breakthrough HIV Prevention Drug Lenacapavir
The US Food and Drug Administration has approved lenacapavir, a breakthrough HIV prevention drug that offers near-complete protection against infection with just two injections a year. According to clinical trial data, the twice-yearly injection is 99% effective at preventing HIV infection in cisgender women and cisgender men. Lenacapavir works by disrupting the HIV virus’s ability … Read more